  Epilepsy is a neurological illness that is characterised by continuous spasms
of shaking, sometimes known as convulsions. Although there are effective
treatments for epilepsy, such as drugs and surgery, there is still a group of
individuals who have intractable epilepsy that fails to respond to standard
methods. Intractable epilepsy is a severe neurological illness that ripples
across the globe and impacts millions of individuals. It is extremely difficult
to control intractable epilepsy, which is defined as the lack of response to
two or more standard antiepileptic medication treatments. In recent years, the
use of programmable electrical stimulation of the brain has shown promise as a
digital treatment strategy for lowering seizure frequency in individuals with
intractable epilepsy. In this research, the use of Amenable Neurostimulation
(ANS) as part of a digital treatment strategy to intractable epilepsy is
investigated. When applied to the brain, ANS uses a closed-loop system to
selectively stimulate neurons in the affected areas, therefore lowering the
frequency of seizures. In addition, the report describes the design and
execution of a pilot research employing ANS to treat intractable epilepsy,
including patient selection criteria, device settings, and outcome measures.
The findings of this pilot research point to the possibility that ANS might be
a realistic and successful therapy option for people afflicted with intractable
epilepsy. This paper demonstrated the prospects of digital medicines in
treating complicated neurological illnesses and recommends future routes for
research and development in this field.
